Clinical Trial Search

Primary: Percentage of Participants Achieving at Least a 20% Reduction From Baseline Hour 0 IOP While on the Same Number or Fewer IOP Lowering Medications at Month 12 — 80.5…

Primary: Mean Intraocular Pressure (IOP) — 15.77; 18.35 millimeters mercury (mm Hg)

Primary: Changes in Vessel Density in Treatment Groups Assessed by OCT Angiography — -0.51; 2.59; -0.96; 0.96 percent change

Primary: Intraocular Pressure in the Study Eye at Month 3 — 18.8; 18.1; 19.7; 19.2 mmHg

Primary: Rate of Hypertensive Phase After Ahmed Valve Implantation for Glaucoma — 9; 12 participants

Primary: Mean Diurnal IOP Change From Baseline at Week 8 — -6.84; -6.00 millimeters mercury (mmHg)

Primary: Change in Mean Unmedicated Diurnal IOP — 7.98 mm Hg

Primary: Change From Baseline in Average Eye Intraocular Pressure (IOP) — 25.350; 25.318; 25.341; 24.650 Millimeters of Mercury (mmHg)

Primary: Presence of Retinal Vascular Dysregulation (RVD) — 7; 4 Participants

Primary: Change From Baseline in Average Eye IOP — 26.16; 25.98; 26.26; 23.91 Millimeters of Mercury (mmHg)

Primary: Change in Intraocular Pressure Between Baseline and 1 Year — 15; 14.7 mmHg

Primary: Intra- Examiner Agreement in Angle Width by Goniometric Lens — 0.88 Kappa statistics

Primary: Postoperative Intraocular Pressure — 14.6; 14.7 mmHg

Primary: Mean Change in Intraocular Pressure at Day 1 — -4.16; -4.57; -0.60 mmHg

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Right Eye — -4.5 mmHg

Primary: Change in Medicated Diurnal Intra-ocular Pressure (IOP) at 6 Months Post-implantation — -8.95 mmHg

Primary: Mean Diurnal IOP Change From Baseline at Month 3 — -8.5; -8.3 millimeters of mercury (mmHg)

Primary: Change From Baseline in IOP (Intraocular Pressure) at End of Study — -1.8 mmHg

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 22.2; -6.7 Millimeters of Mercury (mmHg)

Primary: Mean Change in the Peak Intraocular Pressure (IOP) Measured Two Hours After Study Drug Administration at Week 12 Compared to Baseline IOP. — -3.73 mmHg — p=<0.0001

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 25.4; -6.3 Millimeters of Mercury (mmHg)

Primary: Intraocular Pressure (IOP) in the Study Eye — 16.5; 16.7; 15.7; 16.1 Millimeters of Mercury (mmHg)

Primary: Change From Baseline in Mean Worse Eye Intraocular Pressure (IOP) at Week 12 — 24.62; 25.12; -10.03; -9.18 mmHg

Primary: Mean Diurnal IOP Change From Baseline at Month 3 — -7.9; -6.5; -6.4 millimeters of mercury (mmHg)

Primary: Change From Baseline in Mean Worse Eye Intraocular Pressure (IOP) Analyzed by Two-Sample T-Test — 25.42; 24.43; -10.45; -8.28 Millimeters of Mercury (mmHg)

Primary: Intraocular Pressure (IOP) — 24.69; 24.66; 24.75; 23.33 mmHg — p=<0.0001

Primary: Mean IOP — 12.7 mmHg

Primary: Intraocular Pressure (IOP) at Baseline — 24.45; 24.38 millimeters of mercury (mmHg)

Primary: Intraocular Pressure After Surgery — 13.1; 16.2 mmHg

Primary: Visual Acuity - Right Eye — 0.015; -0.044; -0.012 logMAR units